{{Rsnum
|rsid=11110077
|Gene=ANKS1B
|Chromosome=12
|position=99872335
|Orientation=plus
|GMAF=0.07438
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=ANKS1B
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 77.5 | 21.6 | 0.9
| HCB | 100.0 | 0.0 | 0.0
| JPT | 99.1 | 0.9 | 0.0
| YRI | 77.5 | 22.5 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 70.4 | 29.6 | 0.0
| LWK | 78.3 | 20.8 | 0.9
| MEX | 89.3 | 10.7 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 83.8 | 16.2 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21107309
|Trait=None
|Title=Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
|RiskAllele=
|Pval=4E-7
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}